{"DataElement":{"publicId":"8127748","version":"1","preferredName":"Minimal Residual Disease Original Leukemia Immunophenotype Lower Limit of Detection Laboratory Procedure Outcome 1 Decimal Place Value","preferredDefinition":"The 1 decimal place numeric laboratory value measured, assigned or computed related to the minimal residual disease original leukemia immunophenotype lower limit of detection in a specimen.","longName":"8155238v1.0:2784509v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"8155238","version":"1","preferredName":"Minimal Residual Disease Original Leukemia Immunophenotype Lower Limit of Detection","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques._Preceding all others in time or being as first made or performed._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._The characterization of a set of cells according to the antigens expressed._The smallest concentration of an analyte that can be determined with a stated precision or confidence.","longName":"2452232v1.0:8155236v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2452232","version":"1","preferredName":"Minimal Residual Disease","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","longName":"C3896","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7AD9-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"8155236","version":"1","preferredName":"Original Leukemia Immunophenotype Detection Limit","preferredDefinition":"Preceding all others in time or being as first made or performed.:A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:The characterization of a set of cells according to the antigens expressed.:The smallest concentration of an analyte that can be determined with a stated precision or confidence.","longName":"C25604:C3161:C20072:C105701","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Original","conceptCode":"C25604","definition":"Preceding all others in time or being as first made or performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunophenotype","conceptCode":"C20072","definition":"The characterization of a set of cells according to the antigens expressed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection Limit","conceptCode":"C105701","definition":"The smallest concentration of an analyte that can be determined with a stated precision or confidence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC1588B7-A581-255A-E053-4EBD850A2412","latestVersionIndicator":"Yes","beginDate":"2022-04-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-07","modifiedBy":"ONEDATA","dateModified":"2022-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC1588B7-A592-255A-E053-4EBD850A2412","latestVersionIndicator":"Yes","beginDate":"2022-04-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-04-07","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":"2022.10.3 Released per ticket request CADSR0001568. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2784509","version":"1","preferredName":"Laboratory Procedure Outcome Integer::1 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"2784509v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2784508","version":"1","preferredName":"Laboratory Procedure Outcome Integer::1 Decimal Place Value","preferredDefinition":"A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:A number with no fractional part.::1:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C45255::1:C42646","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F02480-7C97-1803-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"ONEDATA","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F02480-7CA8-1803-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"KUMMEROA","dateModified":"2012-09-12","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_AML_mrd_low_orig_1de_val","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_ALL_mrd_low_orig_1de_val","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the value of the mini","type":"Preferred Question Text","description":"What is the value of the minimal residual disease original leukemia immunophenotype lower limit of detection?","url":null,"context":"NHLBI"},{"name":"What is the lower limit of detection:","type":"Application Standard Question Text","description":"What is the lower limit of detection:","url":null,"context":"NHLBI"},{"name":"What is the lower limit of detection:","type":"Alternate Question Text","description":"What is the lower limit of detection:","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Lower limit of detection:","url":null,"context":"NHLBI"},{"name":"NMDP Text 2","type":"Alternate Question Text","description":"Lower limit of measurable residual disease detection:","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB7234CD-AA24-07C4-E053-4EBD850A7EDA","latestVersionIndicator":"Yes","beginDate":"2022-03-30","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-03-30","modifiedBy":"KUMMEROA","dateModified":"2022-10-03","changeDescription":null,"administrativeNotes":"2022.10.3 Released per ticket request CADSR0001568. ak","unresolvedIssues":null,"deletedIndicator":"No"}}